[1] |
Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol, 2013, 12(10): 999-1010. doi: 10.1016/S1474-4422(13)70168-6.
doi: 10.1016/S1474-4422(13)70168-6
pmid: 23972913
|
[2] |
Thwaites GE, Duc Bang N, Huy Dung N, et al. The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis. J Infect Dis, 2005, 192(12): 2134-2141. doi: 10.1086/498220.
doi: 10.1086/498220
pmid: 16288379
|
[3] |
Wang G, Wang S, Jiang G, et al. Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: A prospective cohort study. J Infect, 2019, 78(4): 311-316. doi: 10.1016/j.jinf.2019.02.010.
doi: 10.1016/j.jinf.2019.02.010
URL
|
[4] |
Bahr NC, Nuwagira E, Evans EE, et al. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study. Lancet Infect Dis, 2018, 18(1): 68-75. doi: 10.1016/S1473-3099(17)30474-7.
doi: 10.1016/S1473-3099(17)30474-7
URL
|
[5] |
Cresswell FV, Tugume L, Bahr NC, et al. Xpert MTB/RIF Ultra for the diagnosis of HIV-associated tuberculous meningitis:a prospective validation study. Lancet Infect Dis, 2020, 20(3): 308-317. doi: 10.1016/S1473-3099(19)30550-X.
doi: S1473-3099(19)30550-X
pmid: 31924549
|
[6] |
Chin JH, Musubire AK, Morgan N, et al. Xpert MTB/RIF Ultra for Detection of Mycobacterium tuberculosis in Cerebrospinal Fluid. J Clin Microbiol, 2019, 57(6): e00249-19. doi: 10.1128/JCM.00249-19.
doi: 10.1128/JCM.00249-19
|
[7] |
Donovan J, Thu DDA, Phu NH, et al. Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study. Lancet Infect Dis, 2020, 20(3):299-307. doi: 10.1016/S1473-3099(19)30649-8.
doi: S1473-3099(19)30649-8
pmid: 31924551
|
[8] |
张培泽, 郑俊峰, 付亮, 等. Xpert MTB/RIF Ultra诊断结核性脑膜炎的价值. 结核病与肺部健康杂志, 2019, 8(1): 42-47. doi: 10.3969/j.issn.2095-3755.2019.01.011.
doi: 10.3969/j.issn.2095-3755.2019.01.011
|
[9] |
Gonzalo-Asensio J, Pérez I, Aguiló N, et al. New insights into the transposition mechanisms of IS6110 and its dynamic distribution between Mycobacterium tuberculosis Complex lineages. PLoS Genet, 2018, 14(4):e1007282. doi: 10.1371/journal.pgen.1007282.
doi: 10.1371/journal.pgen.1007282
URL
|
[10] |
Chakravorty S, Simmons AM, Rowneki M, et al. The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing. mBio, 2017, 8(4): e00812-17. doi: 10.1128/mBio.00812-17.
doi: 10.1128/mBio.00812-17
|
[11] |
Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010, 10(11): 803-812. doi: 10.1016/S1473-3099(10)70138-9.
doi: 10.1016/S1473-3099(10)70138-9
URL
|
[12] |
中国防痨协会基础专业委员会. 结核病诊断实验室检验规程. 北京: 中国教育文化出版社, 2006: 8-45.
|
[13] |
Boehme CC, Nabeta P, Hillemann D, et al. Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N Engl J Med, 2010, 363(11):1005-1015. doi: 10.1056/NEJMoa0907847.
doi: 10.1056/NEJMoa0907847
URL
|
[14] |
Steingart KR, Schiller I, Horne DJ, et al. Xpert®MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev, 2014, 2014(1):CD009593. doi: 10.1002/14651858.CD009593.pub3.
doi: 10.1002/14651858.CD009593.pub3
|
[15] |
García-Basteiro AL, Saavedra B, Cobelens F. The Good, the Bad and the Ugly of the Next-Generation Xpert Mtb/Rif® Ultra Test for Tuberculosis Diagnosis. Arch Bronconeumol, 2017, 53(12): 665-666. doi: 10.1016/j.arbres.2017.05.023.
doi: 10.1016/j.arbres.2017.05.023
URL
|
[16] |
World Health Organization. WHO meeting report of a technical expert consultation: non-inferiority analysis of Xpert MTB/RIF ultra compared to Xpert MTB/RIF. Geneva:World Health Organization, 2017.
|
[17] |
World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization, 2017.
|
[18] |
Patel VB, Connolly C, Singh R, et al. Comparison of amplicor and GeneXpert MTB/RIF tests for diagnosis of tuberculous meningitis. J Clin Microbiol, 2014, 52(10): 3777-3780. doi: 10.1128/JCM.01235-14.
doi: 10.1128/JCM.01235-14
URL
|
[19] |
Nhu NT, Heemskerk D, Thu DD, et al. Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis. J Clin Microbiol, 2014, 52(1): 226-233. doi: 10.1128/JCM.01834-13.
doi: 10.1128/JCM.01834-13
URL
|
[20] |
Thwaites GE, Caws M, Chau TT, et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol, 2004, 42(3): 996-1002. doi: 10.1128/jcm.42.3.996-1002.2004.
doi: 10.1128/jcm.42.3.996-1002.2004
pmid: 15004044
|
[21] |
Thwaites GE, Nguyen TN, Dung NH, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis, 2005, 192(1): 79-88. doi: 10.1086/430616.
doi: 10.1086/430616
pmid: 15942897
|
[22] |
World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update. Geneva: World Health Organization, 2013.
|
[23] |
Roychowdhury T, Mandal S, Bhattacharya A. Analysis of IS6110 insertion sites provide a glimpse into genome evolution of Mycobacterium tuberculosis. Sci Rep, 2015, 5: 12567. doi: 10.1038/srep12567.
doi: 10.1038/srep12567
pmid: 26215170
|
[24] |
Chen H, He L, Cai C, et al. Characteristics of distribution of Mycobacterium tuberculosis lineages in China. Sci China Life Sci, 2018, 61(6): 651-659. doi: 10.1007/s11427-017-9243-0.
doi: 10.1007/s11427-017-9243-0
URL
|